Combating Cancer with Gene Therapy Frost & Sullivan to Host Interactive Quarterly Analyst Briefing on Gene Therapy in the Cancer Treatment Markets on Tuesday, June 28, 2005.
The Technical Insights group at Frost & Sullivan is pleased to announce its exclusive 2005 Quarterly Industry Analyst Briefing on gene therapy in the cancer treatment market to be held on Tuesday, June 28, 2005 at 1:00pm EDT / 12:00pm CDT. The briefing will provide manufacturers, researchers in pharmaceutical and biotech companies and other industry participants with an overview of the current state of gene-therapy technologies focused on the treatment of cancer. The briefing will discuss various types of technologies under development for improved gene delivery and different gene therapy approaches for selective killing of tumor cells. Highlights of the briefing include technology overview, industry trends, key drivers, barriers to commercialization and an insight into important clinical trails. "Cancer continues to be the primary target for gene therapy with more than 2.5 million new cases of cancer diagnosed each year worldwide. Today an increased knowledge about the role of genes in cancer has led to the development of novel cancer therapies," says Frost & Sullivan Technical Insights Research Analyst, A.N. Aditya. The presentation will discuss some of the latest happenings and technology trends in this sector. Government, public and private initiatives will also be discussed. This free teleconference will cover the overview of the gene therapy in the cancer treatment market, the future outlook of emerging technologies and an interactive question and answer session. Those interested in participating in this exclusive analyst briefing should send an email to Danielle White, [EMAIL PROTECTED], with the following information for registration: full Name, company name, title, telephone number, fax number, city, state, address, and email address. Upon receipt of the above information, a confirmation/pass code for the live briefing will be emailed to you. Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com. Contacts Frost & Sullivan, San Antonio Corporate Communications - Healthcare Danielle White, 210-247-2403 [EMAIL PROTECTED] http://www.frost.com http://www.arizonabiotech.com/ http://groups.yahoo.com/group/biotech-news/ http://www.azhttp.com/ http://www.arizonabiotech.com/ <a href="http://www.arizonabiotech.com/";>Arizona Biotech</a> http://groups.yahoo.com/group/biotech-news/ <a href="http://groups.yahoo.com/group/biotech-news/";>Biotech News</a> http://www.arizonaentrepreneurs.com/ <a href="http://www.arizonaentrepreneurs.com/";>Arizona Entrepreneurs</a> http://www.azhttp.com/ <a href="http://www.azhttp.com/";>Arizona High Tech</a> Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
